The RFK Jr announcement and the July 23-24, 2026 Pharmacy Compounding Advisory Committee meeting concern 503A compounding classification, not finished-drug approval
Cagrilintide and semaglutide are not two versions of the same thing they work through fundamentally different receptor systems
Continued large-scale trials are needed to strengthen translational conclusions
By activating both incretin pathways simultaneously, tirzepatide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetitemechanisms that collectively improve glycaemic control and promote weight loss
Products, pricing and availability may vary by geographical location
To eliminate bias, mice of the same sex, age, and genetic strain were randomly assigned to each experimental group